<DOC>
	<DOCNO>NCT01573897</DOCNO>
	<brief_summary>Sleep apnea syndrome ( SAS ) common comorbidity type 1 type 2 diabetes . A low transcutaneous oxygen tension ( PtcO2 ) measure foot pejorative prognostic factor heal diabetic foot wound . SAS cause intermittent nocturnal hypoxia sympathetic overactivity . The investigator hypothesize SAS could factor reduce PtcO2.Therefore , main objective study assess variation PtcO2 end night midday patient -or risk of- diabetic foot wound accord presence sleep apnea syndrome.The secondary objective address microvascularisation diabetic patient foot wound accord status regard sleep apnea syndrome .</brief_summary>
	<brief_title>Impact Sleep Apnea Diabetic Foot Wound</brief_title>
	<detailed_description>The study observational , cross-sectional . Presence sleep apnea syndrome assess night main outcome , difference PtcO2 5:00 AM 12:00AM . Microvascularisation assess Laser Speckle Contrast Imaging Analysis ( LASCA ) . Sample size estimate 60 patient base previous revascularisation study PtcO2 main outcome . An intermediary analysis plan 40 inclusion .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<criteria>Types 1 2 MODY diabetes diabetic foot wound ( risk foot wound stage 2 3 ( see reference PMID:18442189 ) . Patients cover social insurance Patients sleep apnea syndrome previously treat positive airway pressure therapy . Patients previously treat additional oxygen therapy . Patient unstable psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Sleep apnea</keyword>
	<keyword>Diabetic foot</keyword>
	<keyword>microcirculation</keyword>
</DOC>